FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2066330966> ?p ?o ?g. }

• W2066330966 endingPage "106" @default.
• W2066330966 startingPage "98" @default.
• W2066330966 abstract "Preclinical studies have identified numerous neuroprotective drugs that attenuate brain damage and improve functional outcome after cerebral ischemia. Despite this success in animal models, neuroprotective therapies in the clinical setting have been unsuccessful. Identification of biochemical markers common to preclinical and clinical cerebral ischemia will provide a more sensitive and objective measure of injury severity and outcome to facilitate clinical management and treatment. However, there are currently no effective biomarkers available for assessment of stroke. Nonerythroid alphaII-spectrin is a cytoskeletal protein that is cleaved by calpain and caspase-3 proteases to signature alphaII-spectrin breakdown products (alphaII-SBDPs) after cerebral ischemia in rodents. This investigation examined accumulation of calpain- and caspase-3-cleaved alphaII-SBDPs in cerebrospinal fluid (CSF) of rodents subjected to 2 hours of transient focal cerebral ischemia produced by middle cerebral artery occlusion (MCAO) followed by reperfusion. After MCAO injury, full-length alphaII-spectrin protein was decreased in brain tissue and increased in CSF from 24 to 72 hours after injury. Whereas alphaII-SBDPs were undetectable in sham-injured control animals, calpain but not caspase-3 specific alphaII-SBDPs were significantly increased in CSF after injury. However, caspase-3 alphaII-SBDPS were observed in CSF of some injured animals. These results indicate that alphaII-SBDPs detected in CSF after injury, particularly those mediated by calpain, may be useful diagnostic indicators of cerebral infarction that can provide important information about specific neurochemical events that have occurred in the brain after acute stroke." @default.
• W2066330966 created "2016-06-24" @default.
• W2066330966 creator A5020636047 @default.
• W2066330966 creator A5023072358 @default.
• W2066330966 creator A5055437280 @default.
• W2066330966 creator A5059902188 @default.
• W2066330966 creator A5076799832 @default.
• W2066330966 creator A5088937087 @default.
• W2066330966 creator A5091478317 @default.
• W2066330966 date "2004-01-01" @default.
• W2066330966 modified "2023-09-24" @default.
• W2066330966 title "Accumulation of Calpain and Caspase-3 Proteolytic Fragments of Brain-Derived αII-Spectrin in Cerebral Spinal Fluid after Middle Cerebral Artery Occlusion in Rats" @default.
• W2066330966 cites W1500878374 @default.
• W2066330966 cites W1544685573 @default.
• W2066330966 cites W1580653784 @default.
• W2066330966 cites W1583781439 @default.
• W2066330966 cites W1597830591 @default.
• W2066330966 cites W1963857988 @default.
• W2066330966 cites W1969195973 @default.
• W2066330966 cites W1973390472 @default.
• W2066330966 cites W1977749822 @default.
• W2066330966 cites W1978898121 @default.
• W2066330966 cites W1981302459 @default.
• W2066330966 cites W2008186920 @default.
• W2066330966 cites W2014292184 @default.
• W2066330966 cites W2015444974 @default.
• W2066330966 cites W2016332747 @default.
• W2066330966 cites W2020822328 @default.
• W2066330966 cites W2021576901 @default.
• W2066330966 cites W2033624750 @default.
• W2066330966 cites W2039441182 @default.
• W2066330966 cites W2041405463 @default.
• W2066330966 cites W2041673157 @default.
• W2066330966 cites W2043674339 @default.
• W2066330966 cites W2044278619 @default.
• W2066330966 cites W2048589355 @default.
• W2066330966 cites W2049278300 @default.
• W2066330966 cites W2049487499 @default.
• W2066330966 cites W2053649709 @default.
• W2066330966 cites W2060351987 @default.
• W2066330966 cites W2066283275 @default.
• W2066330966 cites W2066464851 @default.
• W2066330966 cites W2068873032 @default.
• W2066330966 cites W2077990191 @default.
• W2066330966 cites W2078579431 @default.
• W2066330966 cites W2082146223 @default.
• W2066330966 cites W2083238163 @default.
• W2066330966 cites W2087876639 @default.
• W2066330966 cites W2088980689 @default.
• W2066330966 cites W2090988963 @default.
• W2066330966 cites W2091771395 @default.
• W2066330966 cites W2104695459 @default.
• W2066330966 cites W2112505121 @default.
• W2066330966 cites W2112646710 @default.
• W2066330966 cites W2123152434 @default.
• W2066330966 cites W2138069622 @default.
• W2066330966 cites W2149023741 @default.
• W2066330966 cites W2149538791 @default.
• W2066330966 cites W2163915075 @default.
• W2066330966 cites W2166117283 @default.
• W2066330966 cites W2169079203 @default.
• W2066330966 cites W2171390337 @default.
• W2066330966 cites W2207633134 @default.
• W2066330966 doi "https://doi.org/10.1097/01.wcb.0000098520.11962.37" @default.
• W2066330966 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/14688621" @default.
• W2066330966 hasPublicationYear "2004" @default.
• W2066330966 type Work @default.
• W2066330966 sameAs 2066330966 @default.
• W2066330966 citedByCount "106" @default.
• W2066330966 countsByYear W20663309662012 @default.
• W2066330966 countsByYear W20663309662013 @default.
• W2066330966 countsByYear W20663309662014 @default.
• W2066330966 countsByYear W20663309662015 @default.
• W2066330966 countsByYear W20663309662016 @default.
• W2066330966 countsByYear W20663309662017 @default.
• W2066330966 countsByYear W20663309662018 @default.
• W2066330966 countsByYear W20663309662019 @default.
• W2066330966 countsByYear W20663309662020 @default.
• W2066330966 countsByYear W20663309662021 @default.
• W2066330966 countsByYear W20663309662022 @default.
• W2066330966 countsByYear W20663309662023 @default.
• W2066330966 crossrefType "journal-article" @default.
• W2066330966 hasAuthorship W2066330966A5020636047 @default.
• W2066330966 hasAuthorship W2066330966A5023072358 @default.
• W2066330966 hasAuthorship W2066330966A5055437280 @default.
• W2066330966 hasAuthorship W2066330966A5059902188 @default.
• W2066330966 hasAuthorship W2066330966A5076799832 @default.
• W2066330966 hasAuthorship W2066330966A5088937087 @default.
• W2066330966 hasAuthorship W2066330966A5091478317 @default.
• W2066330966 hasBestOaLocation W20663309661 @default.
• W2066330966 hasConcept C126322002 @default.
• W2066330966 hasConcept C127413603 @default.
• W2066330966 hasConcept C142669718 @default.
• W2066330966 hasConcept C142724271 @default.
• W2066330966 hasConcept C1491633281 @default.
• W2066330966 hasConcept C181199279 @default.
• W2066330966 hasConcept C182220744 @default.
• W2066330966 hasConcept C25498285 @default.

• next